Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,488 | -25,981 | -12,358 | -19,784 | -13,304 |
| Depreciation Amortization | 39 | 19 | 8 | 20 | 13 |
| Accounts payable and accrued liabilities | 5,030 | 7,690 | 563 | 854 | 731 |
| Other Working Capital | -4,786 | 2,444 | 1,563 | 1,846 | 164 |
| Other Operating Activity | 5,285 | 3,120 | 4,766 | 985 | 1,096 |
| Operating Cash Flow | $-27,920 | $-12,708 | $-5,458 | $-16,079 | $-11,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -457 | -61 | -18 | -48 | -43 |
| Investing Cash Flow | $-457 | $-61 | $-18 | $-48 | $-43 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,015 | 1 | N/A | 20,672 | 4 |
| Other Financing Activity | -3,357 | 0 | 0 | -1,645 | 0 |
| Financing Cash Flow | $42,658 | $1 | $N/A | $19,027 | $4 |
| Beginning Cash Position | 17,525 | 17,525 | 17,525 | 14,625 | 14,625 |
| End Cash Position | 31,806 | 4,757 | 12,049 | 17,525 | 3,286 |
| Net Cash Flow | $14,281 | $-12,768 | $-5,476 | $2,900 | $-11,339 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,920 | -12,708 | -5,458 | -16,079 | -11,300 |
| Capital Expenditure | -457 | -61 | -18 | -48 | -43 |
| Free Cash Flow | -28,377 | -12,769 | -5,476 | -16,127 | -11,343 |